Cargando…

New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease

The relationship between Cyclin-Dependent Kinase Inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) variants rs1333049 G/C and rs4977574 A/G and the risk of coronary heart disease is unclear. We conducted an update analysis incorporating odds ratios and 95% confidence intervals to assess the correlation. Fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Wei, Zhang, Wei, Ruan, Zhong-Bao, Zhu, Li, Liu, Yu, Mi, Yuan-Yuan, Zhang, Li-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291866/
https://www.ncbi.nlm.nih.gov/pubmed/33054494
http://dx.doi.org/10.1080/21655979.2020.1827892
_version_ 1783724727717593088
author Yuan, Wei
Zhang, Wei
Zhang, Wei
Ruan, Zhong-Bao
Zhu, Li
Liu, Yu
Mi, Yuan-Yuan
Zhang, Li-Feng
author_facet Yuan, Wei
Zhang, Wei
Zhang, Wei
Ruan, Zhong-Bao
Zhu, Li
Liu, Yu
Mi, Yuan-Yuan
Zhang, Li-Feng
author_sort Yuan, Wei
collection PubMed
description The relationship between Cyclin-Dependent Kinase Inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) variants rs1333049 G/C and rs4977574 A/G and the risk of coronary heart disease is unclear. We conducted an update analysis incorporating odds ratios and 95% confidence intervals to assess the correlation. Furthermore, we used in silico analysis to investigate the genes and proteins that interact with CDKN2B. Fifty case-control studies with a sample size of 35,915 cases and 48,873 controls were involved. We revealed that the rs1333049 C allele could increase the risk of coronary heart disease in the overall analysis (allele comparison, OR = 1.13, 95%CI = 1.05–1.21, P = 0.001; homozygous contrast, OR = 1.29, 95%CI = 1.11–1.49, P = 0.001; dominant comparison, OR = 1.14, 95%CI = 1.03–1.27, P = 0.011; recessive comparison, OR = 1.21, 95%CI = 1.10–1.34, P < 0.001). In subgroup analysis, positive correlations were detected in studies involving West and East Asians and in population-based control studies. The rs4977574 G allele was also a risk factor for coronary heart disease (allelic comparison, P = 0.001; heterozygous comparison, P = 0.003; homozygous comparison, P < 0.001; dominant comparison, P = 0.001). These results indicate correlation of CDKN2B-AS1 rs1333049 G/C and rs4977574 A/G variants may be correlated with the risk of coronary heart disease. Abbreviations CDK: Cyclin Dependent Kinase; CCND: G1/S-specific cyclin-D; CDKN: Cyclin Dependent Kinase Inhibitor; GWAS: Genome-wide association study; CDKN2B-AS1: Cyclin-Dependent Kinase Inhibitors 2B Antisense RNA 1; CHD: Coronary heart disease; MAF: minor allele frequencies; HWE: Hardy-Weinberg equilibrium of controls; CI: confidence interval; COL8A2: Collagen type VIII alpha 2 chain; HB: Hospital-based; ORs: odds ratios; ITGA11: Integrin subunit alpha 11; LTBP: Latent transforming factor beta binding protein; PB: Population-based; IBC: Itmat Broad Care; NA: Not applicable; PCR-RFLP: polymerase chain reaction-restriction fragment length polymorphism; MI: Myocardial Infarction; SNP: single nucleotide polymorphism; SMAD: Mothers against decapentaplegic homolog; RT-PCR: Real-time polymerase chain reaction; UK: United Kingdom
format Online
Article
Text
id pubmed-8291866
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-82918662021-09-01 New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease Yuan, Wei Zhang, Wei Zhang, Wei Ruan, Zhong-Bao Zhu, Li Liu, Yu Mi, Yuan-Yuan Zhang, Li-Feng Bioengineered Research Paper The relationship between Cyclin-Dependent Kinase Inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) variants rs1333049 G/C and rs4977574 A/G and the risk of coronary heart disease is unclear. We conducted an update analysis incorporating odds ratios and 95% confidence intervals to assess the correlation. Furthermore, we used in silico analysis to investigate the genes and proteins that interact with CDKN2B. Fifty case-control studies with a sample size of 35,915 cases and 48,873 controls were involved. We revealed that the rs1333049 C allele could increase the risk of coronary heart disease in the overall analysis (allele comparison, OR = 1.13, 95%CI = 1.05–1.21, P = 0.001; homozygous contrast, OR = 1.29, 95%CI = 1.11–1.49, P = 0.001; dominant comparison, OR = 1.14, 95%CI = 1.03–1.27, P = 0.011; recessive comparison, OR = 1.21, 95%CI = 1.10–1.34, P < 0.001). In subgroup analysis, positive correlations were detected in studies involving West and East Asians and in population-based control studies. The rs4977574 G allele was also a risk factor for coronary heart disease (allelic comparison, P = 0.001; heterozygous comparison, P = 0.003; homozygous comparison, P < 0.001; dominant comparison, P = 0.001). These results indicate correlation of CDKN2B-AS1 rs1333049 G/C and rs4977574 A/G variants may be correlated with the risk of coronary heart disease. Abbreviations CDK: Cyclin Dependent Kinase; CCND: G1/S-specific cyclin-D; CDKN: Cyclin Dependent Kinase Inhibitor; GWAS: Genome-wide association study; CDKN2B-AS1: Cyclin-Dependent Kinase Inhibitors 2B Antisense RNA 1; CHD: Coronary heart disease; MAF: minor allele frequencies; HWE: Hardy-Weinberg equilibrium of controls; CI: confidence interval; COL8A2: Collagen type VIII alpha 2 chain; HB: Hospital-based; ORs: odds ratios; ITGA11: Integrin subunit alpha 11; LTBP: Latent transforming factor beta binding protein; PB: Population-based; IBC: Itmat Broad Care; NA: Not applicable; PCR-RFLP: polymerase chain reaction-restriction fragment length polymorphism; MI: Myocardial Infarction; SNP: single nucleotide polymorphism; SMAD: Mothers against decapentaplegic homolog; RT-PCR: Real-time polymerase chain reaction; UK: United Kingdom Taylor & Francis 2020-10-14 /pmc/articles/PMC8291866/ /pubmed/33054494 http://dx.doi.org/10.1080/21655979.2020.1827892 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Yuan, Wei
Zhang, Wei
Zhang, Wei
Ruan, Zhong-Bao
Zhu, Li
Liu, Yu
Mi, Yuan-Yuan
Zhang, Li-Feng
New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease
title New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease
title_full New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease
title_fullStr New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease
title_full_unstemmed New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease
title_short New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease
title_sort new findings in the roles of cyclin-dependent kinase inhibitors 2b antisense rna 1 (cdkn2b-as1) rs1333049 g/c and rs4977574 a/g variants on the risk to coronary heart disease
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291866/
https://www.ncbi.nlm.nih.gov/pubmed/33054494
http://dx.doi.org/10.1080/21655979.2020.1827892
work_keys_str_mv AT yuanwei newfindingsintherolesofcyclindependentkinaseinhibitors2bantisenserna1cdkn2bas1rs1333049gcandrs4977574agvariantsontherisktocoronaryheartdisease
AT zhangwei newfindingsintherolesofcyclindependentkinaseinhibitors2bantisenserna1cdkn2bas1rs1333049gcandrs4977574agvariantsontherisktocoronaryheartdisease
AT zhangwei newfindingsintherolesofcyclindependentkinaseinhibitors2bantisenserna1cdkn2bas1rs1333049gcandrs4977574agvariantsontherisktocoronaryheartdisease
AT ruanzhongbao newfindingsintherolesofcyclindependentkinaseinhibitors2bantisenserna1cdkn2bas1rs1333049gcandrs4977574agvariantsontherisktocoronaryheartdisease
AT zhuli newfindingsintherolesofcyclindependentkinaseinhibitors2bantisenserna1cdkn2bas1rs1333049gcandrs4977574agvariantsontherisktocoronaryheartdisease
AT liuyu newfindingsintherolesofcyclindependentkinaseinhibitors2bantisenserna1cdkn2bas1rs1333049gcandrs4977574agvariantsontherisktocoronaryheartdisease
AT miyuanyuan newfindingsintherolesofcyclindependentkinaseinhibitors2bantisenserna1cdkn2bas1rs1333049gcandrs4977574agvariantsontherisktocoronaryheartdisease
AT zhanglifeng newfindingsintherolesofcyclindependentkinaseinhibitors2bantisenserna1cdkn2bas1rs1333049gcandrs4977574agvariantsontherisktocoronaryheartdisease